Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Paricalcitol Oral Therapy in Predialysis CKD Patients. The Greek Experience

NCT01083186 is registered in ClinicalTrials.gov with AbbVie (prior sponsor, Abbott) as lead sponsor.

NCT NCT01083186
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT01083186 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Paricalcitol Oral Therapy in Predialysis CKD Patients. The Greek Experience
Lead sponsor
AbbVie (prior sponsor, Abbott)
Phase
Observational
Overall status
Completed
Start date
June 30, 2009
Completion date
January 31, 2012
Enrollment
500 (actual)
Sites
24

Conditions

As the registry lists them; a condition with its own page is linked.

chronic kidney failure, secondary hyperparathyroidism